Soleno Therapeutics posts Q3 profit as VYKAT XR adoption grows, doubling revenue. Learn about EU expansion plans, analyst concerns, and future outlook.

The FDA warned consumers about potential serious adverse events linked to radiofrequency microneedling procedures.

R&D Expenses: Research and development expenses for the quarter ended September 30, 2025, were $9.4 million, compared to $9.7 million for the quarter ended September 30, 2024. The expenses were ...

GAITHERSBURG, Md., US, November 7, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative ...

Q3 2025 Earnings Call Transcript November 4, 2025 Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

Direct-to-consumer (DTC) telehealth companies remove barriers to care, but questions remain regarding patient safety and proper information.

The transaction has been approved by the boards of directors of both companies and is currently expected to close in the quarter ending March 31, 2026, subject to Gulf Island shareholder approval, ...

Pfizer Inc. (NYSE: PFE) today issued the following statement in response to the Delaware Chancery Court's decision denying Pfizer's request for a temporary restraining order to prevent Metsera, Inc.

The FDA in October requested additional sensitivity analyses of clinical efficacy data from Rhythm’s Phase 3 pivotal trial in acquired hypothalamic obesity. No new data were requested. The additional ...

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence ...

Soleno Therapeutics (($SLNO)) has held its Q3 earnings call. Read on for the main highlights of the call. Soleno Therapeutics’ recent earnings ...

NAPLES, FL / ACCESS Newswire / November 7, 2025 / Rain Enhancement Technologies Holdco, Inc. (the "Company") (Nasdaq:RAIN, RAINW), today announced that it has regained compliance with the continued ...